Pierre Péterlin
Pierre Péterlin publishes mostly in Hematology, Genetics and Oncology, on topics such as Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation and Chronic Myeloid Leukemia Treatments.
- World rank
- #985,477 of 7,710,434 ranked researchers
- Rank in France
- #46,490 of 324,115
- Works
- 340
- Citations
- 4.2k
- Citations per work
- 12.5
What does Pierre Péterlin research?
Pierre Péterlin's work is mostly in Medicine (60%), Immunology and Microbiology (8%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences20259.5%
- Medicine20259.5%
- Everything else8224.0%
- Life Sciences5616.5%
- 1Hematology35% of their works
- 2Genetics10% of their works
- 3Oncology9% of their works
- 4Immunology8% of their works
- 5Molecular Biology8% of their works
- 6Infectious Diseases5% of their works
Research topics
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Acute Lymphoblastic Leukemia research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Multiple Myeloma Research and Treatments
- Histone Deacetylase Inhibitors Research
Which keywords describe Pierre Péterlin's research?
The keywords of their largest research topics: Prognostic Factors, Hematopoietic Stem Cells, Acute Myeloid Leukemia, AML, Bone Marrow Niche, Graft-versus-Host Disease, Minimal Residual Disease and BCR-ABL.
- HDAC Inhibitors
- Diagnosis Criteria
- Chronic Lymphocytic Leukemia
- JAK2 Mutation
- Acute Lymphoblastic Leukemia
- BCR-ABL
- Graft-versus-Host Disease
- Acute Myeloid Leukemia
- Hematopoietic Stem Cells
- Prognostic Factors
- AML
- Bone Marrow Niche
- Minimal Residual Disease
- Imatinib
- Childhood Cancer
- Myelofibrosis
- Genomic Aberrations
- International Myeloma Working Group
- Histone Deacetylases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Prognostic Factors2573 topics
- Hematopoietic Stem Cells2562 topics
- AML1771 topic
- Acute Myeloid Leukemia1771 topic
- Bone Marrow Niche791 topic
- Graft-versus-Host Disease791 topic
- Minimal Residual Disease772 topics
- BCR-ABL551 topic
- Imatinib551 topic
- Acute Lymphoblastic Leukemia471 topic
- Childhood Cancer471 topic
- JAK2 Mutation451 topic
- Myelofibrosis451 topic
- Chronic Lymphocytic Leukemia331 topic
- Genomic Aberrations331 topic
- Diagnosis Criteria301 topic
- International Myeloma Working Group301 topic
- HDAC Inhibitors251 topic
- Histone Deacetylases251 topic
Where does Pierre Péterlin work?
Pierre Péterlin's main affiliation in the publication record is Nantes Université, France.
How many publications and citations does Pierre Péterlin have?
OpenAlex counts 340 works and 4,234 citations for Pierre Péterlin, an h-index of 36, ranking #985,477 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Pierre Péterlin. Posts are plain text and can be reported.